BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 33195662)

  • 1. Idiopathic multicentric Castleman disease with pulmonary and cutaneous lesions treated with tocilizumab: A case report.
    Han PY; Chi HH; Su YT
    World J Clin Cases; 2020 Oct; 8(20):4922-4929. PubMed ID: 33195662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of acute progressive diffuse interstitial lung disease preceding idiopathic multicentric Castleman disease.
    Nabeya D; Yoshimatsu Y; Fujiwara H
    Respir Med Case Rep; 2020; 31():101216. PubMed ID: 32995258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic multicentric Castleman disease treated with siltuximab for 15 years: a case report.
    Lang E; Sande B; Brodkin S; van Rhee F
    Ther Adv Hematol; 2022; 13():20406207221082552. PubMed ID: 35251585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of idiopathic multicentric Castleman disease with pulmonary hyalinizing granuloma-like multiple pulmonary nodules.
    Hatano H; Tsujimoto Y; Watanabe H; Tsukada A; Izumi S; Nagasaka S; Igari T; Suzuki M; Iikura M; Hojo M
    Respir Investig; 2023 Jul; 61(4):405-408. PubMed ID: 37099891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of renal biopsy in differentiating idiopathic multicentric Castleman disease from IgG4-related disease.
    Kawanishi M; Kamei F; Sonoda H; Oba M; Fukunaga S; Egawa M; Koyama T; Sato Y; Tanabe K; Ito T
    CEN Case Rep; 2023 May; 12(2):242-248. PubMed ID: 36414812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic multicentric Castleman disease with Sjögren's syndrome and secondary membranous nephropathy: a case report and review of the literature.
    Pan Y; Cui Z; Wang S; Zheng D; Deng Z; Tian X; Guo H; Bao W; Zhou S; Wang Y
    BMC Nephrol; 2020 Dec; 21(1):528. PubMed ID: 33276741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Afebrile Pneumonia in a Patient With Multicentric Castleman Disease on Siltuximab: Infection Without Fever on Anti-Interleukin-6 Therapy.
    Cohen PR; Nikanjam M; Kato S; Goodman AM; Kurzrock R
    Cureus; 2020 Jul; 12(7):e8967. PubMed ID: 32766009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADA2 Deficiency Mimicking Idiopathic Multicentric Castleman Disease.
    Van Nieuwenhove E; Humblet-Baron S; Van Eyck L; De Somer L; Dooley J; Tousseyn T; Hershfield M; Liston A; Wouters C
    Pediatrics; 2018 Sep; 142(3):. PubMed ID: 30139808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dichotomic response to interleukin-6 blockade in idiopathic multicentric Castleman disease: two case reports.
    Ferrero S; Ragaini S
    J Med Case Rep; 2021 Mar; 15(1):105. PubMed ID: 33676575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic Multicentric Castleman Disease with Strikingly Elevated IgG4 Concentration in the Serum and Abundant IgG4-Positive Cells in the Tissue: A Case Report.
    Cheng CC; Chen YC; Hsu YH; Su KY
    Diagnostics (Basel); 2022 Sep; 12(9):. PubMed ID: 36140662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.
    Fajgenbaum DC; Uldrick TS; Bagg A; Frank D; Wu D; Srkalovic G; Simpson D; Liu AY; Menke D; Chandrakasan S; Lechowicz MJ; Wong RS; Pierson S; Paessler M; Rossi JF; Ide M; Ruth J; Croglio M; Suarez A; Krymskaya V; Chadburn A; Colleoni G; Nasta S; Jayanthan R; Nabel CS; Casper C; Dispenzieri A; Fosså A; Kelleher D; Kurzrock R; Voorhees P; Dogan A; Yoshizaki K; van Rhee F; Oksenhendler E; Jaffe ES; Elenitoba-Johnson KS; Lim MS
    Blood; 2017 Mar; 129(12):1646-1657. PubMed ID: 28087540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of Pulmonary Involvement in Idiopathic Multicentric Castleman Disease-Not Otherwise Specified: From Nodules to Cysts or Consolidation.
    Zhou J; Zhang L; Liu X; Zhang M; Li J; Zhang W
    Chest; 2023 Aug; 164(2):418-428. PubMed ID: 36963752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous Plasmacytosis and Idiopathic Multicentric Castleman Disease: A Spectrum of Disease?
    Drissi M; Dunlap R; Clayton L; Raess PW; Mengden Koon S; White K
    Am J Dermatopathol; 2022 Apr; 44(4):294-296. PubMed ID: 34966045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schnitzler syndrome co-occurring with idiopathic multicentric Castleman disease that responds to anti-IL-1 therapy: A case report and clue to pathophysiology.
    Soudet S; Fajgenbaum D; Delattre C; Forestier A; Hachulla E; Hatron PY; Launay D; Terriou L
    Curr Res Transl Med; 2018 Sep; 66(3):83-86. PubMed ID: 30108026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Potential Clinical Benefit of Tocilizumab Therapy for Patients with HHV-8-infected AIDS-related Multicentric Castleman Disease: A Case Report and Literature Review.
    Barlingay G; Findakly D; Hartmann C; Amar S
    Cureus; 2020 Apr; 12(4):e7589. PubMed ID: 32399323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy.
    Fajgenbaum DC; van Rhee F; Nabel CS
    Blood; 2014 May; 123(19):2924-33. PubMed ID: 24622327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic multicentric Castleman disease preceded by cutaneous plasmacytosis successfully treated by tocilizumab.
    Aita T; Hamaguchi S; Shimotani Y; Nakamoto Y
    BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33148595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are Patients with HHV-8 Associated Castleman Disease Successfully Treated with Rituximab at Risk of Subsequently Developing HHV-8 Negative (Idiopathic) Castleman Disease?
    Ha G; Kwong K; Tanaka B; Nishimura Y; Chong C
    Eur J Case Rep Intern Med; 2023; 10(7):003904. PubMed ID: 37455698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare Association Between Idiopathic Multicentric Castleman Disease, Nephrotic Syndrome and Polyneuropathy in an Immunocompetent Patient.
    Landeiro L; Freitas AC; Proença M; Cabeçadas J; Nunes A; Bayão Horta A
    Eur J Case Rep Intern Med; 2021; 8(10):002831. PubMed ID: 34790625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic multicentric Castleman disease presenting progressive reticular honeycomb infiltration of lung and immunoglobulin G and immunoglobulin G4 dominant hypergammaglobulinemia: a case report.
    Kim HJ; Hong YH
    J Yeungnam Med Sci; 2022 Apr; 39(2):153-160. PubMed ID: 34218552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.